Status:
COMPLETED
Ammonia N-13 Myocardial Blood Flow Absolute Quantification by PET in Patients With Known or Suspected CAD (Ammonia MAP)
Lead Sponsor:
Ionetix Corporation
Conditions:
Myocardial Ischemia
Coronary Disease
Eligibility:
All Genders
18+ years
Brief Summary
This study is being conducted to provide access to and collect test data for an established nuclear medicine diagnostic imaging test called Positron Emission Tomography (PET), using a specific radioac...
Detailed Description
This is a prospective, multicenter database that will be populated by sites utilizing N-13 Ammonia and sponsored by Ionetix. Each site with access to N-13 produced under an investigational new drug (I...
Eligibility Criteria
Inclusion
- Adults ≥18 able to give informed consent.
- Clinical indication for PET-MPI as determined by the subject's treating physician
Exclusion
- Any clinical contraindication for pharmacologic stress testing per ASNC/SNMMI/ACC myocardial perfusion imaging guidelines when stress perfusion imaging is required clinically.
- Inability or unwilling to give informed consent
- Pregnant subjects
Key Trial Info
Start Date :
September 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2024
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04343209
Start Date
September 14 2020
End Date
August 16 2024
Last Update
September 5 2024
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Doral Imaging Institute, LLC dba CIRA
Miami, Florida, United States, 33165
2
Doral Imaging Institute, LLC DBA CIRA Miami Beach
Miami Beach, Florida, United States, 33140
3
Adler Institute for Advanced Imaging
Jenkintown, Pennsylvania, United States, 19046
4
UPMC
Pittsburgh, Pennsylvania, United States, 15213